Cyclosporine is used to treat immune-mediated and allergic conditions and to prevent transplant rejection. To determine the prevalence of bacterial infections during cyclosporine therapy in dogs, 2 databases were searched and 14 articles reporting usable data were identified. In 828 dogs with atopic dermatitis receiving anti-allergic dosages of cyclosporine, the prevalence of bacterial infections was 11%; these occurred most often in the integument and urinary systems and not in multiple systems. In 95 dogs receiving cyclosporine at higher dosages for other conditions, the prevalence of bacterial infection was 17%, and these infections occurred most often in the gastrointestinal, urinary, and respiratory systems, often occurring at more than one body site. The prevalence of bacterial infections in atopic dogs treated with cyclosporine is low and occurs most often in the skin. When given for immunosuppression, the prevalence of bacterial infections is higher and can affect one or more body systems.This survey assessed how veterinary point-of-care ultrasound (VPOCUS), including abdominal and thoracic focused assessment with sonography for trauma (AFAST, TFAST), is used across Canada. Seventy-four veterinarians completed an online survey; 88% (65/74) used ultrasound, 94% (61/65) performed AFAST, and 69% (45/65) performed TFAST. Reasons for not performing VPOCUS included no machine/poor quality machine, lack of experience/confidence, and lack of training/education. Abdominal effusion, and pleural and pericardial effusion were the most frequently diagnosed AFAST and TFAST pathologies, respectively. Lung and cardiovascular ultrasound examinations were infrequently performed. Subpleural consolidation was rarely included in VPOCUS. Most respondents performed VPOCUS, with AFAST being more frequently and confidently preformed than TFAST. More training, education, and standardization of techniques appear to be key elements to help build confidence and experience, particularly with regard to TFAST applications and diagnosis.Methicillin-resistant Staphylococcus pseudintermedius skin infections are an increasing concern in veterinary medicine, especially when found in juvenile dogs with no prior antimicrobial exposure. The objectives of this study were to assess the prevalence of methicillin-resistant staphylococci in breeding bitches and survey antimicrobial administration by their breeders. A total of 17 breeders and 54 bitches were included. Bitches were housed in diverse environments throughout the Phoenix, Arizona, USA metropolitan region. Nasal and oral gingival swabs were submitted for selective culture. Methicillin-resistant Staphylococcus aureus was not present, while methicillin-resistant Staphylococcus pseudintermedius was found in only 1/54 (1.9%) dogs. Survey results revealed that 16 bitches, which did not include the 1 MRSP-positive dog, had received antimicrobials within 6 months prior to sampling. Regardless of the low point prevalence identified, veterinarians and breeders should be cognizant of risks for bacterial resistance with the overuse of antimicrobials.The condition of 640 male dairy calves was recorded and their health deterioration, morbidity, and mortality evaluated after long-distance transport. Assessments included a health examination, weight estimation, and measure of failed transfer of passive immunity (FTPI). A McNemar Test and logistic regression analysis were used to evaluate the effects of pre-transport condition on subsequent health. Before transport, calf health and age at shipping varied between farms; overall, 17%, 8%, and 12% of calves had diarrhea, navel disease, and FTPI, respectively, and calves were transported at a median age of 5 days. In their first 2 weeks after transportation, 23% and 44% of calves were treated for diarrhea and bovine respiratory disease (BRD), respectively, and 4% died. Calves with navel disease, low body weight, and a depressed attitude at the farm of origin were more likely to experience negative health outcomes. Better health before transportation is needed to protect the subsequent health and welfare of young calves.Key Takeaways In Washington, the City of Bellevue wanted to break away from the inefficiency of siloed operations and create a unified, data-based, smart-city strategy across all city departments. The Bellevue Smart Team tested a water module in its new City Portal, starting with a dashboard that would organize and optimize data for a better customer, utility, and city experience.  https://www.selleckchem.com/products/Decitabine.html  The platform used to set up the City Portal allows for flexibility in adding modules and adopting new technologies.Shallow-depth sequencing of cell-free DNA, a cheap and standardized approach to obtain molecular information on tumors non-invasively, is insufficiently explored for lymphoma diagnosis and disease follow-up. This study collected 318 samples, including longitudinal liquid and paired solid biopsies, from a prospectively recruited cohort of 38 Hodgkin lymphoma (HL) and 85 aggressive B-cell non- HL patients, represented by 81 diffuse large B-cell lymphoma (DLBCL) cases. Following sequencing, copy number alterations and viral read fractions were derived and analyzed. At diagnosis, liquid biopsies showed detectable copy number alterations in 84.2% of HL (88.6% for classical HL) and 74.1% of DLBCL patients. Copy number profiles between liquid-solid pairs were highly concordant within DLBCL (r=0.815±0.043); and, compared to tissue, HL liquid biopsies had abnormalities with higher amplitudes (P=.010), implying that tumor DNA is more abundant in plasma. Additionally, 39.5% of HL and 13.6% of DLBCL cases had a significantly elevated number of plasmatic Epstein-Barr virus DNA fragments, achieving a sensitivity of 100% compared to current standard. Longitudinal analysis determined that, when detectable, copy number patterns were similar across (re)staging moments in refractory/relapsed patients. Moreover, the overall profile anomaly highly correlated with the total metabolic tumor volume (P.Not available.Antibodies against polyethylene glycol (PEG) in healthy subjects raise concerns about the efficacy of pegylated drugs. We evaluated the prevalence of antibodies against PEG among patients with acute lymphoblastic leukemia (ALL) prior to and/or immediately after their first dose of pegylated E.coli asparaginase (PEG-ASNase). Serum samples of 701 children, 673 with primary ALL, 28 with relapsed ALL, and 188 adults with primary ALL were analyzed for anti-PEG IgG and IgM. Measurements in 58 healthy infants served as reference to define cut-points for antibody-positive and -negative samples. Anti-PEG antibodies were detected in ALL patients prior the first PEG-ASNase with a prevalence of 13.9% (anti-PEG IgG) and 29.1% (anti-PEG IgM). After administration of PEG-ASNase the prevalence of anti-PEG antibodies decreased to 4.2% for anti-PEG IgG and to 4.5% for anti-PEG IgM. Pre-existing anti-PEG antibodies did not inhibit PEG-ASNase activity but significantly reduced PEGASNase activity levels in a concentration dependent manner.